Accelerate Diagnostics, Inc.

NasdaqCM:AXDX Stock Report

Market Cap: US$41.8m

Accelerate Diagnostics Management

Management criteria checks 1/4

Accelerate Diagnostics' CEO is Jack Phillips, appointed in Feb 2020, has a tenure of 4.75 years. total yearly compensation is $3.00M, comprised of 19.8% salary and 80.2% bonuses, including company stock and options. directly owns 0.69% of the company’s shares, worth $287.75K. The average tenure of the management team and the board of directors is 1.8 years and 4.5 years respectively.

Key information

Jack Phillips

Chief executive officer

US$3.0m

Total compensation

CEO salary percentage19.8%
CEO tenure4.8yrs
CEO ownership0.7%
Management average tenure1.8yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Market Participants Recognise Accelerate Diagnostics, Inc.'s (NASDAQ:AXDX) Revenues Pushing Shares 38% Higher

Apr 17
Market Participants Recognise Accelerate Diagnostics, Inc.'s (NASDAQ:AXDX) Revenues Pushing Shares 38% Higher

Accelerate Diagnostics spikes as Chief Technology Officer raises stake

Aug 30

Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Aug 20
Need To Know: Analysts Are Much More Bullish On Accelerate Diagnostics, Inc. (NASDAQ:AXDX)

Accelerate Diagnostics jumps 14% after beating Q2 estimates

Aug 15

Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Mar 15
Need To Know: The Consensus Just Cut Its Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Estimates For 2022

Accelerate Diagnostics And T2 Biosystems: Financial Woes Set To Continue In 2022

Jan 04

Accelerate Diagnostics: An Investment Assessment

Sep 07

Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Feb 20
Should You Take Comfort From Insider Transactions At Accelerate Diagnostics, Inc. (NASDAQ:AXDX)?

Accelerate Diagnostics foresees Q4 and FY2020 revenue below consensus

Jan 12

Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

Dec 29
Reflecting on Accelerate Diagnostics' (NASDAQ:AXDX) Share Price Returns Over The Last Three Years

CEO Compensation Analysis

How has Jack Phillips's remuneration changed compared to Accelerate Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-US$53m

Jun 30 2024n/an/a

-US$38m

Mar 31 2024n/an/a

-US$59m

Dec 31 2023US$3mUS$595k

-US$62m

Sep 30 2023n/an/a

-US$63m

Jun 30 2023n/an/a

-US$80m

Mar 31 2023n/an/a

-US$66m

Dec 31 2022US$2mUS$595k

-US$62m

Sep 30 2022n/an/a

-US$71m

Jun 30 2022n/an/a

-US$64m

Mar 31 2022n/an/a

-US$67m

Dec 31 2021US$3mUS$595k

-US$78m

Sep 30 2021n/an/a

-US$74m

Jun 30 2021n/an/a

-US$84m

Mar 31 2021n/an/a

-US$81m

Dec 31 2020US$4mUS$555k

-US$78m

Sep 30 2020n/an/a

-US$81m

Jun 30 2020n/an/a

-US$82m

Mar 31 2020n/an/a

-US$84m

Dec 31 2019US$12mUS$162k

-US$84m

Compensation vs Market: Jack's total compensation ($USD3.00M) is above average for companies of similar size in the US market ($USD652.28K).

Compensation vs Earnings: Jack's compensation has increased whilst the company is unprofitable.


CEO

Jack Phillips (58 yo)

4.8yrs

Tenure

US$3,004,105

Compensation

Mr. Jack Phillips has been Chief Executive Officer, President and Director of Accelerate Diagnostics, Inc. since February 1, 2020. Mr. Phillips served as Chief Operating Officer of Accelerate Diagnostics,...


Leadership Team

NamePositionTenureCompensationOwnership
Jack Phillips
CEO, President & Director4.8yrsUS$3.00m0.69%
$ 287.8k
David Patience
Chief Financial Officer1.6yrsUS$1.16m0.22%
$ 90.4k
Lawrence Mertz
Chief Technology Officer2.4yrsUS$952.16k0.35%
$ 144.9k
Maya Gowri
Senior VP & Head of Operations1.8yrsno datano data
Laura Pierson
Investor Relations Officerno datano datano data
John Meduri
Chief Strategy Officer8.7yrsno datano data
Chris Thode
Senior Vice President of US Commercial1.8yrsno datano data
Rita Boukamel
Senior VP & Head of EMEA1.7yrsno datano data

1.8yrs

Average Tenure

58yo

Average Age

Experienced Management: AXDX's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Jack Phillips
CEO, President & Director4.8yrsUS$3.00m0.69%
$ 287.8k
John Patience
Independent Director12.4yrsUS$231.32k2.83%
$ 1.2m
Jack Schuler
Independent Director12.4yrsUS$231.32k36.05%
$ 15.1m
Hany Massarany
Independent Chairman of the Board4.5yrsUS$231.32k0.17%
$ 70.5k
Louise Francesconi
Independent Director4.9yrsUS$231.32k0.14%
$ 59.3k
Marran J. Ogilvie
Independent Director1.5yrsUS$233.68kno data
Marin Kollef
Scientific Advisory Board Memberno datano datano data
Connie Price
Scientific Advisory Board Memberno datano datano data
Mark Black
Independent Director1.5yrsUS$233.68kno data
Richard Wunderink
Scientific Advisory Board Memberno datano datano data
Wayne Burris
Independent Director2.8yrsUS$231.32k0.0071%
$ 3.0k
Jenny Regan
Independent Director1.5yrsUS$233.68k0.053%
$ 22.3k

4.5yrs

Average Tenure

65yo

Average Age

Experienced Board: AXDX's board of directors are considered experienced (4.5 years average tenure).